Literature DB >> 22536923

Epigenetic mechanisms in anti-cancer actions of bioactive food components--the implications in cancer prevention.

B Stefanska1, H Karlic, F Varga, K Fabianowska-Majewska, Ag Haslberger.   

Abstract

The hallmarks of carcinogenesis are aberrations in gene expression and protein function caused by both genetic and epigenetic modifications. Epigenetics refers to the changes in gene expression programming that alter the phenotype in the absence of a change in DNA sequence. Epigenetic modifications, which include amongst others DNA methylation, covalent modifications of histone tails and regulation by non-coding RNAs, play a significant role in normal development and genome stability. The changes are dynamic and serve as an adaptation mechanism to a wide variety of environmental and social factors including diet. A number of studies have provided evidence that some natural bioactive compounds found in food and herbs can modulate gene expression by targeting different elements of the epigenetic machinery. Nutrients that are components of one-carbon metabolism, such as folate, riboflavin, pyridoxine, cobalamin, choline, betaine and methionine, affect DNA methylation by regulating the levels of S-adenosyl-L-methionine, a methyl group donor, and S-adenosyl-L-homocysteine, which is an inhibitor of enzymes catalyzing the DNA methylation reaction. Other natural compounds target histone modifications and levels of non-coding RNAs such as vitamin D, which recruits histone acetylases, or resveratrol, which activates the deacetylase sirtuin and regulates oncogenic and tumour suppressor micro-RNAs. As epigenetic abnormalities have been shown to be both causative and contributing factors in different health conditions including cancer, natural compounds that are direct or indirect regulators of the epigenome constitute an excellent approach in cancer prevention and potentially in anti-cancer therapy.
© 2012 The Authors. British Journal of Pharmacology © 2012 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22536923      PMCID: PMC3481038          DOI: 10.1111/j.1476-5381.2012.02002.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  245 in total

1.  Histone modification levels are predictive for gene expression.

Authors:  Rosa Karlić; Ho-Ryun Chung; Julia Lasserre; Kristian Vlahovicek; Martin Vingron
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

2.  Inhibition of DNA biosynthesis in HeLa cells by cytotoxic and antitumor sesquiterpene lactones.

Authors:  J M Woynarowski; J Konopa
Journal:  Mol Pharmacol       Date:  1981-01       Impact factor: 4.436

3.  AKT and p21 WAF1/CIP1 as potential genistein targets in BRCA1-mutant human breast cancer cell lines.

Authors:  Maud Privat; Corinne Aubel; Stephanie Arnould; Yves Communal; Marc Ferrara; Yves-Jean Bignon
Journal:  Anticancer Res       Date:  2010-06       Impact factor: 2.480

Review 4.  Dietary histone deacetylase inhibitors: from cells to mice to man.

Authors:  Roderick H Dashwood; Emily Ho
Journal:  Semin Cancer Biol       Date:  2007-05-05       Impact factor: 15.707

5.  Quercetin is able to demethylate the p16INK4a gene promoter.

Authors:  Sainan Tan; Chong Wang; Cailing Lu; Baojian Zhao; Yi Cui; Xinquan Shi; Xu Ma
Journal:  Chemotherapy       Date:  2008-10-31       Impact factor: 2.544

6.  Folate and one-carbon metabolism nutrients from supplements and diet in relation to breast cancer risk.

Authors:  Sonia S Maruti; Cornelia M Ulrich; Emily White
Journal:  Am J Clin Nutr       Date:  2008-12-30       Impact factor: 7.045

7.  Curcumin is a potent DNA hypomethylation agent.

Authors:  Zhongfa Liu; Zhiliang Xie; William Jones; Ryan E Pavlovicz; Shujun Liu; Jianhua Yu; Pui-kai Li; Jiayuh Lin; Jame R Fuchs; Guido Marcucci; Chenglong Li; Kenneth K Chan
Journal:  Bioorg Med Chem Lett       Date:  2008-12-14       Impact factor: 2.823

8.  Hypomethylation effects of curcumin, demethoxycurcumin and bisdemethoxycurcumin on WIF-1 promoter in non-small cell lung cancer cell lines.

Authors:  Yu-Liang Liu; He-Ping Yang; Liang Gong; Chun-Lan Tang; Hai-Jing Wang
Journal:  Mol Med Rep       Date:  2011-04-11       Impact factor: 2.952

9.  Impact of vitamin D metabolism on clinical epigenetics.

Authors:  Heidrun Karlic; Franz Varga
Journal:  Clin Epigenetics       Date:  2011-02-08       Impact factor: 6.551

10.  Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome.

Authors:  Dana C Dolinoy; Jennifer R Weidman; Robert A Waterland; Randy L Jirtle
Journal:  Environ Health Perspect       Date:  2006-04       Impact factor: 9.031

View more
  48 in total

1.  Functional genomics analysis of vitamin D effects on CD4+ T cells in vivo in experimental autoimmune encephalomyelitis ‬.

Authors:  Manuel Zeitelhofer; Milena Z Adzemovic; David Gomez-Cabrero; Petra Bergman; Sonja Hochmeister; Marie N'diaye; Atul Paulson; Sabrina Ruhrmann; Malin Almgren; Jesper N Tegnér; Tomas J Ekström; André Ortlieb Guerreiro-Cacais; Maja Jagodic
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-14       Impact factor: 11.205

Review 2.  Epigenetics and cancer metabolism.

Authors:  Christelle Johnson; Marc O Warmoes; Xiling Shen; Jason W Locasale
Journal:  Cancer Lett       Date:  2013-10-11       Impact factor: 8.679

Review 3.  Maternal diet, bioactive molecules, and exercising as reprogramming tools of metabolic programming.

Authors:  Paulo C F Mathias; Ghada Elmhiri; Júlio C de Oliveira; Carine Delayre-Orthez; Luiz F Barella; Laize P Tófolo; Gabriel S Fabricio; Abalo Chango; Latifa Abdennebi-Najar
Journal:  Eur J Nutr       Date:  2014-01-28       Impact factor: 5.614

4.  Rising rates of colorectal cancer among younger Iranians: is diet to blame?

Authors:  S Hessami Arani; M A Kerachian
Journal:  Curr Oncol       Date:  2017-04-27       Impact factor: 3.677

5.  γ-Aminobutyric acid inhibits the proliferation and increases oxaliplatin sensitivity in human colon cancer cells.

Authors:  Lihua Song; Aiying Du; Ying Xiong; Jing Jiang; Yao Zhang; Zhaofeng Tian; Hongli Yan
Journal:  Tumour Biol       Date:  2016-09-19

6.  Epigenetics and pharmacology.

Authors:  Barbara Stefanska; David J MacEwan
Journal:  Br J Pharmacol       Date:  2015-06       Impact factor: 8.739

Review 7.  Epigenetic effects of green tea polyphenols in cancer.

Authors:  Susanne M Henning; Piwen Wang; Catherine L Carpenter; David Heber
Journal:  Epigenomics       Date:  2013-12       Impact factor: 4.778

8.  Childhood Leukemia and Primary Prevention.

Authors:  Todd P Whitehead; Catherine Metayer; Joseph L Wiemels; Amanda W Singer; Mark D Miller
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2016-10

Review 9.  Epigenetic modifications by dietary phytochemicals: implications for personalized nutrition.

Authors:  Sharmila Shankar; Dhruv Kumar; Rakesh K Srivastava
Journal:  Pharmacol Ther       Date:  2012-11-16       Impact factor: 12.310

10.  Vitamin D intake is negatively associated with promoter methylation of the Wnt antagonist gene DKK1 in a large group of colorectal cancer patients.

Authors:  James B Rawson; Zhouyu Sun; Elizabeth Dicks; Darshana Daftary; Patrick S Parfrey; Roger C Green; Steven Gallinger; John R McLaughlin; Peizhong P Wang; Julia A Knight; Bharati Bapat
Journal:  Nutr Cancer       Date:  2012-09-11       Impact factor: 2.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.